A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation
Clinical trial NCT07406854 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07406854
- Sponsor
- Wuhan Neurophth Biotechnology Limited Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-19
- Primary completion
- 2026-05-30
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.